Patient review and registration program increases oversight of opioid prescription trends.
Laurie Toich, Assistant Editor
Advertisement
Articles by Laurie Toich, Assistant Editor
HDAC inhibitors in combination with immune-stimulating agents improve tumor response.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Controversial 340B Rebate Pilot Program Is Moving Forward
2
Striking the Balance: Evidence-Based versus Defensive Medicine
3
Carefully Consider Ethical Implications of Artificial Intelligence Use in Pharmacy
4
Researchers Identify Key Lipid Pathways That Influence Alzheimer’s Progression
5
